Faizan Farooque

Faizan Farooque

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

3 Homebuilding Stocks To Profit From the Residential Surge

Homebuilding stocks did well in 2020 despite the pandemic. And with normalcy now somewhat returning, these companies will do even better.

SOS Stock Is Both Way Overvalued and Too High-Risk to Take a Chance

SOS has a solid core business model making it an enticing prospect. But heavy dilution and steep valuation make SOS stock risky right now.

Plug Power Is an Excellent Short-Term Trade After Sharp Pullback

PLUG stock has fallen nearly 16%, giving you an excellent opportunity to take profits on the back renewable energy tailwinds.

3 Reasons Why the Ethereum Bull Run Shows No Signs of Slowing Down

Interest in Ethereum will continue to rise as institutional demand increases with the launch of the CME Ether futures contract.

Ocugen Stock Is an Excellent Day Trade as Long as You Get Out in Time

OCGN stock is not a buy-and-hold investment yet; however, its association with India's Bharat Biotech will continue to drive shares up.